The Effect of Vibration Treatments Combined with Teriparatide or Strontium Ranelate on Bone Healing and Muscle in Ovariectomized Rats

Calcif Tissue Int. 2016 Oct;99(4):408-22. doi: 10.1007/s00223-016-0156-0. Epub 2016 Jun 6.

Abstract

The aim of the present study was to study the effect of combined therapy of teriparatide (PTH) or strontium ranelate (SR) with whole-body vibration (WBV) on bone healing and muscle properties in an osteopenic rat model. Seventy-two rats (3 months old) were bilaterally ovariectomized (Ovx), and 12 rats were left intact (Non-Ovx). After 8 weeks, bilateral transverse osteotomy was performed at the tibia metaphysis in all rats. Thereafter, Ovx rats were divided into six groups (n = 12): (1) Ovx-no treatment, (2) Ovx + vibration (Vib), (3) SR, (4) SR + Vib, (5) PTH, and (6) PTH + Vib. PTH (40 μg/kg BW sc. 5×/week) and SR (613 mg/kg BW in food daily) were applied on the day of ovariectomy, vibration treatments 5 days later (vertical, 70 Hz, 0.5 mm, 2×/day for 15 min) for up to 6 weeks. In the WBV + SR group, the callus density, trabecular number, and Alp and Oc gene expression were decreased compared to SR alone. In the WBV + PTH group, the cortical and callus widths, biomechanical properties, Opg gene expression, and Opg/Rankl ratio were increased; the cortical and callus densities were decreased compared to PTH alone. A case of non-bridging was found in both vibrated groups. Vibration alone did not change the bone parameters; PTH possessed a stronger effect than SR therapy. In muscles, combined therapies improved the fiber size of Ovx rats. WBV could be applied alone or in combination with anti-osteoporosis drug therapy to improve muscle tissue. However, in patients with fractures, anti-osteoporosis treatments and the application of vibration could have an adverse effect on bone healing.

Keywords: Bone healing; Combined therapy; Muscle structure; Strontium ranelate; Teriparatide; Whole-body vibration.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Body Weight
  • Bone Density / drug effects
  • Bone Density Conservation Agents / therapeutic use*
  • Bone and Bones / metabolism
  • Bone and Bones / pathology
  • Female
  • Fracture Healing / drug effects
  • Fractures, Bone / drug therapy
  • Osteoporosis / drug therapy*
  • Osteotomy
  • Ovariectomy
  • Rats
  • Rats, Sprague-Dawley
  • Teriparatide / administration & dosage*
  • Thiophenes / administration & dosage*
  • Vibration / therapeutic use*

Substances

  • Bone Density Conservation Agents
  • Thiophenes
  • strontium ranelate
  • Teriparatide